Endovascular intervention for peripheral artery disease
AK Thukkani, S Kinlay - Circulation research, 2015 - Am Heart Assoc
Advances in endovascular therapies during the past decade have broadened the options for
treating peripheral vascular disease percutaneously. Endovascular treatment offers a lower …
treating peripheral vascular disease percutaneously. Endovascular treatment offers a lower …
Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month …
G Tepe, J Laird, P Schneider, M Brodmann… - Circulation, 2015 - Am Heart Assoc
Background—Drug-coated balloons (DCBs) have shown promise in improving the
outcomes for patients with peripheral artery disease. We compared a paclitaxel-coated …
outcomes for patients with peripheral artery disease. We compared a paclitaxel-coated …
Drug-coated balloon treatment for lower extremity vascular disease intervention: an international positioning document
The advent of drug-coated balloons (DCBs) provides a novel means to locally deliver
paclitaxel into the arterial wall without the need of a chronically implanted delivery system …
paclitaxel into the arterial wall without the need of a chronically implanted delivery system …
Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCImer Laser …
EJ Dippel, P Makam, R Kovach, JC George… - JACC: Cardiovascular …, 2015 - jacc.org
Objectives: The purpose of this study was to evaluate the safety and efficacy of excimer laser
atherectomy (ELA) with adjunctive percutaneous transluminal angioplasty (PTA) versus PTA …
atherectomy (ELA) with adjunctive percutaneous transluminal angioplasty (PTA) versus PTA …
Drug-coated balloons for complex femoropopliteal lesions: 2-year results of a real-world registry
A Schmidt, M Piorkowski, H Görner, S Steiner… - JACC: Cardiovascular …, 2016 - jacc.org
Objectives: The authors sought to investigate the efficacy of a drug-coated balloon (DCB) for
treatment of complex femoropopliteal lesions. Background: Superiority of DCBs compared …
treatment of complex femoropopliteal lesions. Background: Superiority of DCBs compared …
Drug-coated balloon versus standard balloon for superficial femoral artery in-stent restenosis: the randomized femoral artery in-stent restenosis (FAIR) trial
H Krankenberg, T Tübler, M Ingwersen, M Schlüter… - Circulation, 2015 - Am Heart Assoc
Background—Drug-coated balloon angioplasty (DCBA) was shown to be superior to
standard balloon angioplasty (POBA) in terms of restenosis prevention for de novo …
standard balloon angioplasty (POBA) in terms of restenosis prevention for de novo …
Paclitaxel-eluting balloon versus standard balloon angioplasty in in-stent restenosis of the superficial femoral and proximal popliteal artery: 1-year results of the …
CM Kinstner, J Lammer, A Willfort-Ehringer… - JACC: Cardiovascular …, 2016 - jacc.org
Objectives: The hypothesis that paclitaxel-eluting balloon angioplasty provides higher 1-
year patency rates in femoropopliteal artery in-stent restenosis compared with standard …
year patency rates in femoropopliteal artery in-stent restenosis compared with standard …
Paclitaxel-eluting balloon vs standard angioplasty to reduce restenosis in diabetic patients with in-stent restenosis of the superficial femoral and proximal popliteal …
S Grotti, F Liistro, P Angioli, K Ducci… - Journal of …, 2016 - journals.sagepub.com
Purpose: To report the 3-year safety and effectiveness outcomes from the prospective all-
comers DEBATE-ISR study (ClinicalTrials. gov identifier NCT01558531) of symptomatic …
comers DEBATE-ISR study (ClinicalTrials. gov identifier NCT01558531) of symptomatic …
Drug-coated balloon treatment for femoropopliteal artery disease: the IN. PACT global study de novo in-stent restenosis imaging cohort
M Brodmann, K Keirse, D Scheinert, L Spak… - JACC: Cardiovascular …, 2017 - jacc.org
Objectives: This study sought to evaluate the safety and effectiveness of a paclitaxel-coated
drug-coated balloon (DCB) for the treatment of patients with de novo in-stent restenosis …
drug-coated balloon (DCB) for the treatment of patients with de novo in-stent restenosis …
ISAR‐PEBIS (paclitaxel‐eluting balloon versus conventional balloon angioplasty for in‐stent restenosis of superficial femoral artery): a randomized trial
I Ott, S Cassese, P Groha, B Steppich… - Journal of the …, 2017 - Am Heart Assoc
Background Paclitaxel‐eluting balloon (PEB) angioplasty has superior efficacy compared
with conventional balloon angioplasty (BA) for de novo lesions of superficial femoral artery …
with conventional balloon angioplasty (BA) for de novo lesions of superficial femoral artery …